News

Vasculotide is a synthetic peptide-based growth factor which targets Tie2, a receptor on specialized cells of the hematopoietic and vascular systems. Vasculotide was invented by Sunnybrook Research Institute

The Culex Automated In Vivo Sampling Services have long offered investigators a means to increase the amount and type of data gathered in drug discovery experiments with small

The Neglected Global Diseases Initiative at NGDI-UBC brings together the technical expertise and perspectives of a variety of disciplines at UBC – including bench science, pharmaceutical and health

The 10 products range initially within a dosage group of tablets and capsules with other dosage forms to follow. The buyer has placed an initial assorted order for

TheraBiogen received orders for zinc free nasal spray products from Imperial Distributors which operates across the Northeast and Mid-Atlantic states. Imperial Distributors will be supplying TheraMax to Big

In addition to the cash payment, each Genzyme shareholder will receive one contingent value right (CVR) for each share they own, entitling the holder to receive additional cash

Warfarin, an anti-clotting drug used since the 1950s, requires patients to have regular testing to monitor its effectiveness and dosage adjustment. According to this most recent update, dabigatran

PRIMACYT Cell Culture Technology GmbH provides in-vitro technology services to the pharmaceutical and biotech industry. It currently offers hepatocyte cells to the drug discovery research community throughout Europe.

The Aeolus contract is valued at $10.4m for the first year and can be extended for a total of five years and up to a total of $118.4m.